Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1094 | 1094 | 1133 | 1059 | 1740 | - |
Fund Return | 9.41% | 9.41% | 13.26% | 1.94% | 11.71% | - |
Place in category | 72 | 72 | 168 | 299 | 24 | - |
% in Category | 15 | 15 | 38 | 73 | 6 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Eurose Class I shares E | 2.43B | 1.42 | 3.88 | 2.77 | ||
DNCA Invest Eurose Class AD shares | 2.43B | 1.24 | 3.14 | 2.04 | ||
DNCA Invest Eurose Class A shares | 2.43B | 1.24 | 3.14 | 2.04 | ||
DNCA Invest Europe Growth Class A s | 1.22B | 7.71 | 4.56 | 8.81 | ||
DNCA Invest Europe Growth Class B s | 1.22B | 7.61 | 4.17 | 8.41 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Europe Growth Class A s | 1.22B | 7.71 | 4.56 | 8.81 | ||
DNCA Invest Europe Growth Class B s | 1.22B | 7.61 | 4.17 | 8.41 | ||
DNCA Invest Europe Growth Class F s | 1.22B | 8.04 | 5.74 | 9.96 | ||
DNCA Invest Europe Growth Class I s | 1.22B | 7.98 | 5.57 | 9.82 | ||
LU1330191385 | 967.53M | 6.20 | 13.61 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 9.54 | 850.6 | -2.58% | |
NKT Holding | DK0010287663 | 6.71 | 562.5 | -0.97% | |
ASML Holding | NL0010273215 | 6.37 | 835.90 | +3.02% | |
Tryg | DK0060636678 | 5.35 | 139.5 | +1.16% | |
Flutter Entertainment | IE00BWT6H894 | 4.82 | 15,705.0 | +2.88% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Strong Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review